Oncologix Tech Stock Market Value
Oncologix Tech's market value is the price at which a share of Oncologix Tech trades on a public exchange. It measures the collective expectations of Oncologix Tech investors about its performance. With this module, you can estimate the performance of a buy and hold strategy of Oncologix Tech and determine expected loss or profit from investing in Oncologix Tech over a given investment horizon. Check out Oncologix Tech Correlation, Oncologix Tech Volatility and Oncologix Tech Alpha and Beta module to complement your research on Oncologix Tech.
Symbol | Oncologix |
Oncologix Tech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oncologix Tech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oncologix Tech.
11/06/2023 |
| 11/30/2024 |
If you would invest 0.00 in Oncologix Tech on November 6, 2023 and sell it all today you would earn a total of 0.00 from holding Oncologix Tech or generate 0.0% return on investment in Oncologix Tech over 390 days. Oncologix Tech is related to or competes with Embrace Change, A SPAC, and Athena Technology. Oncologix Tech, Inc., a diversified medical holding company, provides health care services in the United States More
Oncologix Tech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oncologix Tech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oncologix Tech upside and downside potential and time the market with a certain degree of confidence.
Oncologix Tech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oncologix Tech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oncologix Tech's standard deviation. In reality, there are many statistical measures that can use Oncologix Tech historical prices to predict the future Oncologix Tech's volatility.Oncologix Tech Backtested Returns
Oncologix Tech maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12% return per unit of risk over the last 3 months. Oncologix Tech exposes zero different technical indicators, which can help you to evaluate volatility embedded in its price movement. The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Oncologix Tech are completely uncorrelated.
Auto-correlation | 0.04 |
Virtually no predictability
Oncologix Tech has virtually no predictability. Overlapping area represents the amount of predictability between Oncologix Tech time series from 6th of November 2023 to 19th of May 2024 and 19th of May 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oncologix Tech price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Oncologix Tech price fluctuation can be explain by its past prices.
Correlation Coefficient | 0.04 | |
Spearman Rank Test | -0.17 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Oncologix Tech lagged returns against current returns
Autocorrelation, which is Oncologix Tech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oncologix Tech's pink sheet expected returns. We can calculate the autocorrelation of Oncologix Tech returns to help us make a trade decision. For example, suppose you find that Oncologix Tech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Oncologix Tech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oncologix Tech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oncologix Tech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oncologix Tech pink sheet over time.
Current vs Lagged Prices |
Timeline |
Oncologix Tech Lagged Returns
When evaluating Oncologix Tech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oncologix Tech pink sheet have on its future price. Oncologix Tech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oncologix Tech autocorrelation shows the relationship between Oncologix Tech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Oncologix Tech.
Regressed Prices |
Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Oncologix Pink Sheet
Oncologix Tech financial ratios help investors to determine whether Oncologix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncologix with respect to the benefits of owning Oncologix Tech security.